Target intelligence / Profile preview

RalBP1-associated Eps domain-containing protein 2 (REPS2)

Target
REPS2
Molecular classification
Other (specifically, adaptor protein involved in signal transduction and endocytosis)
01

Overview

RalBP1-associated Eps domain-containing protein 2 (REPS2) is a protein product encoded by the REPS2 gene. It functions as part of a protein complex that regulates the endocytosis of growth factor receptors, interacting directly with a GTPase activating protein downstream of the small G protein Ral. Through these interactions, REPS2 may influence receptor internalization and growth factor signaling, as well as cell adhesion and migration via connections with ASAP1. Multiple isoforms of REPS2 exist due to alternative splicing. REPS2 is downregulated in prostate cancer progression and is associated with diseases such as Nance-Horan Syndrome and autism spectrum disorder. The protein interacts with EPN1, EPS15, RALBP1, but is not currently recognized as a direct therapeutic target, and no drugs are known to interact with it.

Other names
REPS2POB1RalBP1-associated Eps domain containing 2RalBP1-interacting protein 2Partner of RalBP1Partner of Ral-binding protein 1
02

Biological functions

Regulation of endocytosis of growth factor receptorsSignal transduction (via Ral signaling pathway)Cell adhesion and migration (via ASAP1)Potential regulation of cell survival and proliferation
03

Disease associations

Cancer (notably, REPS2 is downregulated during prostate cancer progression and inhibits growth factor signaling in prostate cancer cells)Nance-Horan Syndrome (identified disease association)Autism Spectrum Disorder (identified disease association)
04

Biomarkers

Downregulation of REPS2/POB1 may serve as a biomarker for prostate cancer progression

Beyond the preview

Go deeper on RalBP1-associated Eps domain-containing protein 2 (REPS2).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on RalBP1-associated Eps domain-containing protein 2 (REPS2).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call